These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 2468325)

  • 1. Virus strain specificity of challenge immunity to coronavirus.
    Barthold SW; Smith AL
    Arch Virol; 1989; 104(3-4):187-96. PubMed ID: 2468325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duration of challenge immunity to coronavirus JHM in mice.
    Barthold SW; Smith AL
    Arch Virol; 1989; 107(3-4):171-7. PubMed ID: 2554852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duration and strain-specificity of immunity to enterotropic mouse hepatitis virus.
    Homberger FR; Barthold SW; Smith AL
    Lab Anim Sci; 1992 Aug; 42(4):347-51. PubMed ID: 1331605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Responses of mice to murine coronavirus immunization.
    Smith AL; de Souza MS; Finzi D; Barthold SW
    Arch Virol; 1992; 125(1-4):39-52. PubMed ID: 1322658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Responses of mice susceptible or resistant to lethal infection with mouse hepatitis virus, strain JHM, after exposure by a natural route.
    Garlinghouse LE; Smith AL
    Lab Anim Sci; 1985 Oct; 35(5):469-72. PubMed ID: 2414512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse hepatitis virus and host determinants of vertical transmission and maternally-derived passive immunity in mice.
    Barthold SW; Beck DS; Smith AL
    Arch Virol; 1988; 100(3-4):171-83. PubMed ID: 2840871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective immunity against murine hepatitis virus (MHV) induced by intranasal or subcutaneous administration of hybrids of tobacco mosaic virus that carries an MHV epitope.
    Koo M; Bendahmane M; Lettieri GA; Paoletti AD; Lane TE; Fitchen JH; Buchmeier MJ; Beachy RN
    Proc Natl Acad Sci U S A; 1999 Jul; 96(14):7774-9. PubMed ID: 10393897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactivities of 4 murine coronavirus antigens with immunized or naturally infected rat sera by enzyme linked immunosorbent assay.
    Machii K; Iwai H; Otsuka Y; Ueda K; Hirano N
    Jikken Dobutsu; 1988 Jul; 37(3):251-5. PubMed ID: 2843391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility of laboratory mice to intranasal and contact infection with coronaviruses of other species.
    Barthold SW; de Souza MS; Smith AL
    Lab Anim Sci; 1990 Sep; 40(5):481-5. PubMed ID: 2170746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response of genetically susceptible and resistant mice to intranasal inoculation with mouse hepatitis virus JHM.
    Barthold SW; Smith AL
    Virus Res; 1987 May; 7(3):225-39. PubMed ID: 3037819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late onset, symptomatic, demyelinating encephalomyelitis in mice infected with MHV-JHM in the presence of maternal antibody.
    Perlman S; Schelper R; Bolger E; Ries D
    Microb Pathog; 1987 Mar; 2(3):185-94. PubMed ID: 2853274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mouse hepatitis virus nasoencephalopathy is dependent upon virus strain and host genotype.
    Barthold SW; Beck DS; Smith AL
    Arch Virol; 1986; 91(3-4):247-56. PubMed ID: 3022679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance of naive mice to murine hepatitis virus strain 3 requires development of a Th1, but not a Th2, response, whereas pre-existing antibody partially protects against primary infection.
    Pope M; Chung SW; Mosmann T; Leibowitz JL; Gorczynski RM; Levy GA
    J Immunol; 1996 May; 156(9):3342-9. PubMed ID: 8617959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal challenge immunity of mice to antigenically homologous and heterologous strains of mouse hepatitis virus.
    Barthold SW; Beck DS
    Adv Exp Med Biol; 1987; 218():449-50. PubMed ID: 2829558
    [No Abstract]   [Full Text] [Related]  

  • 15. Epitope-specific antibody response to murine hepatitis virus-4 (strain JHM).
    Talbot PJ; Salmi AA; Knobler RL; Buchmeier MJ
    J Immunol; 1985 Feb; 134(2):1217-24. PubMed ID: 2578156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duration of mouse hepatitis virus infection: studies in immunocompetent and chemically immunosuppressed mice.
    Barthold SW; Smith AL
    Lab Anim Sci; 1990 Mar; 40(2):133-7. PubMed ID: 2157090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasally administered alpha/beta interferon prevents extension of mouse hepatitis virus, strain JHM, into the brains of BALB/cByJ mice.
    Smith AL; Barthold SW; Beck DS
    Antiviral Res; 1987 Dec; 8(5-6):239-45. PubMed ID: 2837142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Passively acquired challenge immunity to enterotropic coronavirus in mice.
    Homberger FR; Barthold SW
    Arch Virol; 1992; 126(1-4):35-43. PubMed ID: 1326267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronavirus-induced encephalomyelitis: balance between protection and immune pathology depends on the immunization schedule with spike protein S.
    Flory E; Stühler A; Barac-Latas V; Lassmann H; Wege H
    J Gen Virol; 1995 Apr; 76 ( Pt 4)():873-9. PubMed ID: 9049333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mouse hepatitis virus spike and nucleocapsid proteins expressed by adenovirus vectors protect mice against a lethal infection.
    Wesseling JG; Godeke GJ; Schijns VE; Prevec L; Graham FL; Horzinek MC; Rottier PJ
    J Gen Virol; 1993 Oct; 74 ( Pt 10)():2061-9. PubMed ID: 8409930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.